No evidence for differential methylation of α-synuclein in leukocyte DNA of Parkinson's disease patients

Movement Disorders

Volumn 27, Issue 4, 2012, Pages 590-591

  Richter, Julia ^a   Appenzeller, Silke ^a   Ammerpohl, Ole ^a   Deuschl, G ^a   Paschen, Steffen ^a   Brüggemann, Norbert ^b   Klein, Christine ^b   Kuhlenbäumer, Gregor ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BIOLOGICAL MARKER; DNA;

ADULT; CLINICAL ARTICLE; CPG ISLAND; FEMALE; HUMAN; LETTER; LEUKOCYTE; MALE; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN METHYLATION;

AGED; ALPHA-SYNUCLEIN; DNA METHYLATION; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 84859422631     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.24907     Document Type: Letter

References (7)

1. Simon-Sanchez J, Schulte C, Bras JM, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet. 2009; 41: 1308-1312.
2. Singleton AB, Farrer M, Johnson J, et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science. 2003; 302: 841.
3. Jowaed A, Schmitt I, Kaut O, Wullner U. Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains. J Neurosci. 2010; 30: 6355-6359.
4. Matsumoto L, Takuma H, Tamaoka A, et al. CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease. PLoS One. 2010; 5 e15522.
5. Lamprecht B, Walter K, Kreher S, et al. Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat Med. 2010; 16: 571-579.
6. Fan S, Zhang X. CpG island methylation pattern in different human tissues and its correlation with gene expression. Biochem Biophys Res Commun. 2009; 383: 421-425.
7. Yuferov V, Nielsen DA, Levran O, et al. Tissue-specific DNA methylation of the human prodynorphin gene in post-mortem brain tissues and PBMCs. Pharmacogenet Genomics. 2011; 21: 185-196.